Cellulitis
☆ Liphethong tsa 2022 Stiftung Warentest tse tsoang Jeremane, khotsofalo ea bareki ka ModelDerm e ne e le tlase hanyane ho feta lipuisano tse lefelloang tsa telemedicine.
Leoto ke sebaka se tloaelehileng bakeng sa Cellulitis.
Nyeoe e tloaelehileng
Mokhahlelo oa ho folisa.
References
Cellulitis ke tšoaetso e tloaelehileng ea letlalo la baktheria. E ama batho ba fetang limilione tse 14 selemo le selemo United States. E lebisa ho hoo e ka bang $ 3. 7 limilione tse likete ka litšenyehelo tsa tlhokomelo ea ambulatory le lipetlele tse 650,000 selemo se seng le se seng. Ka tloaelo, cellulitis e hlaha e le sebaka se futhumetseng, se khubelu letlalong ka ho ruruha le bonolo. E bakoa ke tšoaetso ea tšohanyetso ea baktheria e bakang ho ruruha ka har'a letlalo le tebileng le lisele tse haufi. Ha ho na abscess kapa boladu ka tshwaetso ena. Beta-hemolytic streptococci, haholo-holo sehlopha A streptococcus (Streptococcus pyogenes) , ke lisosa tse tloaelehileng, tse lateloang ke methicillin-sensitive Staphylococcus aureus.
Cellulitis is a common bacterial skin infection, with over 14 million cases occurring in the United States annually. It accounts for approximately 3.7 billion dollars in ambulatory care costs and 650000 hospitalizations annually. Cellulitis typically presents as a poorly demarcated, warm, erythematous area with associated edema and tenderness to palpation. It is an acute bacterial infection causing inflammation of the deep dermis and surrounding subcutaneous tissue. The infection is without an abscess or purulent discharge. Beta-hemolytic streptococci typically cause cellulitis, generally group A streptococcus (i.e., Streptococcus pyogenes), followed by methicillin-sensitive Staphylococcus aureus. Patients who are immunocompromised, colonized with methicillin-resistant Staphylococcus aureus, bitten by animals, or have comorbidities such as diabetes mellitus may become infected with other bacteria.
Cellulitis is a common bacterial skin infection, with over 14 million cases occurring in the United States annually. It accounts for approximately 3.7 billion dollars in ambulatory care costs and 650000 hospitalizations annually. Cellulitis typically presents as a poorly demarcated, warm, erythematous area with associated edema and tenderness to palpation. It is an acute bacterial infection causing inflammation of the deep dermis and surrounding subcutaneous tissue. The infection is without an abscess or purulent discharge. Beta-hemolytic streptococci typically cause cellulitis, generally group A streptococcus (i.e., Streptococcus pyogenes), followed by methicillin-sensitive Staphylococcus aureus. Patients who are immunocompromised, colonized with methicillin-resistant Staphylococcus aureus, bitten by animals, or have comorbidities such as diabetes mellitus may become infected with other bacteria.
Cellulitis ke tšoaetso ea baktheria ea letlalo le lisele tse bonolo. E etsahala ha ho na le mathata a tšireletso ea letlalo, sesole sa 'mele kapa phallo ea mali. Lefu la tsoekere, botenya, le botsofali li eketsa menyetla ea cellulitis ka ho ama libaka tsena. Re boetse re sheba liphuputso tsa morao-rao mabapi le ho hlahloba cellulitis , ho totobatsa bohlokoa ba ho hlahloba ka nepo kaha maemo a kang ho haella ha venous, eczema, deep vein thrombosis, le gout hangata a ferekanngoa le cellulitis. Lithibela-mafu tse sebelisoang ho alafa cellulitis li khethoa ka hloko ho lebisa libaktheria tse tloaelehileng ntle le ho khothaletsa khanyetso ea lithibela-mafu. Re boetse re bua ka lithibela-mafu tse ncha tse lumelletsoeng cellulitis. Cellulitis hangata e khutla ka lebaka la mabaka a kotsi a tsoelang pele le tšenyo ea lymphatic system.
Cellulitis is a bacterial infection of the skin and soft tissues. It happens when there are issues with the skin's protective barrier, the immune system, or blood circulation. Diabetes, obesity, and old age increase the chances of cellulitis by affecting these areas. We also look at recent findings on diagnosing cellulitis, highlighting the importance of accurate diagnosis since conditions like venous insufficiency, eczema, deep vein thrombosis, and gout are often confused with cellulitis. Antibiotics used to treat cellulitis are chosen carefully to target common bacteria without encouraging antibiotic resistance. We also talk about new antibiotics approved for cellulitis. Cellulitis often comes back because of ongoing risk factors and damage to the lymphatic system..
Cellulitis is a bacterial infection of the skin and soft tissues. It happens when there are issues with the skin's protective barrier, the immune system, or blood circulation. Diabetes, obesity, and old age increase the chances of cellulitis by affecting these areas. We also look at recent findings on diagnosing cellulitis, highlighting the importance of accurate diagnosis since conditions like venous insufficiency, eczema, deep vein thrombosis, and gout are often confused with cellulitis. Antibiotics used to treat cellulitis are chosen carefully to target common bacteria without encouraging antibiotic resistance. We also talk about new antibiotics approved for cellulitis. Cellulitis often comes back because of ongoing risk factors and damage to the lymphatic system..
Batho ba bangata ba ea lipetlele kapa likamoreng tsa maemo a tšohanyetso bakeng sa mafu a tšohanyetso a bakoang ke baktheria. Staphylococcus aureus ke kokoana-hloko e bakang mafu ana, 'me ho thata ho alafa hobane mefuta e meng e hanana le lithibela-mafu tse tloaelehileng.
Acute bacterial skin and skin-structure infections are a common reason for seeking care at acute healthcare facilities, including emergency departments. Staphylococcus aureus is the most common organism associated with these infections, and the emergence of community-associated methicillin-resistant Staphylococcus aureus (MRSA) has represented a considerable challenge in their treatment.
Acute bacterial skin and skin-structure infections are a common reason for seeking care at acute healthcare facilities, including emergency departments. Staphylococcus aureus is the most common organism associated with these infections, and the emergence of community-associated methicillin-resistant Staphylococcus aureus (MRSA) has represented a considerable challenge in their treatment.
Staphylococcus aureus e ka aroloa ka mefuta e 'meli ho latela karabelo ea bona ho lithibela-mafu: methicillin-sensitive Staphylococcus aureus (MSSA) , methicillin-resistant Staphylococcus aureus (MRSA) . Lilemong tse mashome a seng makae tse fetileng, ka lebaka la ho iphetola ha baktheria le tšebeliso e feteletseng ea lithibela-mafu, khanyetso ea S. Aureus ho lithethefatsi e ntse e eketseha, e leng se lebisang keketsehong ea lefats'e ea MRSA # litekanyetso tsa ts'oaetso.
According to the sensitivity to antibiotic drugs, S. aureus can be divided into methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA). In recent decades, due to the evolution of bacteria and the abuse of antibiotics, the drug resistance of S. aureus has gradually increased, the infection rate of MRSA has increased worldwide.
According to the sensitivity to antibiotic drugs, S. aureus can be divided into methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA). In recent decades, due to the evolution of bacteria and the abuse of antibiotics, the drug resistance of S. aureus has gradually increased, the infection rate of MRSA has increased worldwide.
To review the salient features of the management of severe skin and soft tissue infections (SSTIs), including toxic shock syndrome, myonecrosis/gas gangrene, and necrotizing fasciitis.
Maoto le sefahleho ke libaka tse atileng haholo tse amehang. Lintho tse kotsi li kenyelletsa botenya, ho ruruha maotong le botsofali. Libaktheria tse amehang hangata ke streptococci le Staphylococcus aureus.
Kalafo hangata e sebelisoa ka lithibela-mafu tse nooang ka molomo, joalo ka cephalexin, amoxicillin kapa cloxacillin. Hoo e ka bang 95% ea batho ba betere kamora matsatsi a 7 ho isa ho a 10 a kalafo. Leha ho le joalo, ba nang le lefu la tsoekere, hangata ba ba le liphello tse mpe haholo.
Cellulitis ke boloetse bo tloaelehileng, 'me United Kingdom, cellulitis e bile sesosa sa 1.6% ea batho ba amoheloang sepetlele. Cellulitis ka 2015 e bakile mafu a ka bang 16,900 lefatšeng ka bophara.
○ Kalafo - Lithethefatsi tsa OTC
Cellulitis e tsoetseng pele e hloka phekolo ka lithibela-mafu tse fanoeng ke ngaka feela. Haeba leqeba le ntse le tsoela pele ka potlako 'me le tsamaisana le feberu le serame, ho eletsoa ho bona ngaka kapele kamoo ho ka khonehang.
Ho tlotsa setlolo sa lithibela-mafu se rekisoang ka nako e telele ho ka thusa. Haeba mafura a sebelisoa a le mosesaane haholo, a ka 'na a se ke a sebetsa ho hang.
#Polysporin
#Bacitracin
#Betadine
Sebelisa lipholisa bohloko tsa OTC joalo ka acetaminophen ho kokobetsa bohloko.
#Ibuprofen
#Naproxen
#Acetaminophen
Boloka maoto a hloekile 'me u phekole leoto la moatlelete hobane leoto la moatlelete le eketsa kotsi ea cellulitis.
○ Kalafo
#First-generation cephalosporins (e.g. Cefradine)
#Bacterial culture
#Third-generation cephalosporins (e.g. Cefditoren Pivoxil)